Ijin Joo1,2, Jeong Min Lee3,4,5, Dong Ho Lee1,2, Ju Hyeon Jeon6, Joon Koo Han1,2,7. 1. Department of Radiology, Seoul National University Hospital, 101 Daehak-ro, Jongno-gu, Seoul, 110-744, Republic of Korea. 2. Department of Radiology, Seoul National University College of Medicine, Seoul, Republic of Korea. 3. Department of Radiology, Seoul National University Hospital, 101 Daehak-ro, Jongno-gu, Seoul, 110-744, Republic of Korea. jmsh@snu.ac.kr. 4. Department of Radiology, Seoul National University College of Medicine, Seoul, Republic of Korea. jmsh@snu.ac.kr. 5. Institute of Radiation Medicine, Seoul National University Medical Research Center, Seoul, Republic of Korea. jmsh@snu.ac.kr. 6. Department of Radiology, Mediplex Sejong Hospital, Incheon, Republic of Korea. 7. Institute of Radiation Medicine, Seoul National University Medical Research Center, Seoul, Republic of Korea.
Abstract
OBJECTIVES: To validate new diagnostic criteria for hepatocellular carcinoma (HCC) on gadoxetic acid-enhanced MR imaging (Gd-EOB-MRI) using hypointensity on the hepatobiliary phase (HBP) as an alternative to washout in combination with ancillary features. METHODS: This retrospective study included 288 patients at high risk for HCC with 387 nodules (HCCs, n=292; non-HCCs, n=95) showing arterial phase hyper-enhancement (APHE) ≥1 cm on Gd-EOB-MRI. Imaging diagnoses of HCCs were made using different criteria: APHE plus hypointensity on the portal venous phase (PVP) (criterion 1), APHE plus hypointensity on the PVP and/or transitional phase (TP) (criterion 2), APHE plus hypointensity on the PVP and/or TP and/or HBP (criterion 3), and criterion 3 plus non-LR-1/2/M according to the Liver Imaging Reporting and Data System (LI-RADS) v2017 considering ancillary features (criterion 4). Sensitivities and specificities of those criteria were compared using McNemar's test. RESULTS: Among diagnostic criteria for HCCs, criteria 3 and 4 showed significantly higher sensitivities (93.8% and 92.5%, respectively) than criteria 1 and 2 (70.9% and 86.6%, respectively) (p values <0.001). The specificity of criterion 4 (87.4%) was shown to be significantly higher than that of criterion 3 (48.4%, p<0.001), albeit comparable to criterion 2 (86.3%, p>0.999) and significantly lower than criterion 1 (97.9%, p=0.002). CONCLUSIONS: In the non-invasive diagnosis of HCCs on Gd-EOB-MRI, HBP hypointensity may be used as an alternative to washout enabling a highly sensitive diagnosis with little loss in specificity if it is used after excluding nodules considered to be benignities or non-HCC malignancies based on characteristic imaging features. KEY POINTS: • Gd-EOB-MRI enhancement and ancillary features can be used to diagnose HCC. • Exclusion of LR-1/2/M improves specificity when HBP hypointensity is used.
OBJECTIVES: To validate new diagnostic criteria for hepatocellular carcinoma (HCC) on gadoxetic acid-enhanced MR imaging (Gd-EOB-MRI) using hypointensity on the hepatobiliary phase (HBP) as an alternative to washout in combination with ancillary features. METHODS: This retrospective study included 288 patients at high risk for HCC with 387 nodules (HCCs, n=292; non-HCCs, n=95) showing arterial phase hyper-enhancement (APHE) ≥1 cm on Gd-EOB-MRI. Imaging diagnoses of HCCs were made using different criteria: APHE plus hypointensity on the portal venous phase (PVP) (criterion 1), APHE plus hypointensity on the PVP and/or transitional phase (TP) (criterion 2), APHE plus hypointensity on the PVP and/or TP and/or HBP (criterion 3), and criterion 3 plus non-LR-1/2/M according to the Liver Imaging Reporting and Data System (LI-RADS) v2017 considering ancillary features (criterion 4). Sensitivities and specificities of those criteria were compared using McNemar's test. RESULTS: Among diagnostic criteria for HCCs, criteria 3 and 4 showed significantly higher sensitivities (93.8% and 92.5%, respectively) than criteria 1 and 2 (70.9% and 86.6%, respectively) (p values <0.001). The specificity of criterion 4 (87.4%) was shown to be significantly higher than that of criterion 3 (48.4%, p<0.001), albeit comparable to criterion 2 (86.3%, p>0.999) and significantly lower than criterion 1 (97.9%, p=0.002). CONCLUSIONS: In the non-invasive diagnosis of HCCs on Gd-EOB-MRI, HBP hypointensity may be used as an alternative to washout enabling a highly sensitive diagnosis with little loss in specificity if it is used after excluding nodules considered to be benignities or non-HCC malignancies based on characteristic imaging features. KEY POINTS: • Gd-EOB-MRI enhancement and ancillary features can be used to diagnose HCC. • Exclusion of LR-1/2/M improves specificity when HBP hypointensity is used.
Entities:
Keywords:
Carcinoma, hepatocellular; Liver; Magnetic resonance imaging; Practice guideline
Authors: Lewis R Roberts; Claude B Sirlin; Feras Zaiem; Jehad Almasri; Larry J Prokop; Julie K Heimbach; M Hassan Murad; Khaled Mohammed Journal: Hepatology Date: 2017-11-29 Impact factor: 17.425
Authors: Sang Hyun Choi; Jae Ho Byun; So Yeon Kim; So Jung Lee; Hyung Jin Won; Yong Moon Shin; Pyo Nyun Kim Journal: Invest Radiol Date: 2016-08 Impact factor: 6.016
Authors: Julius Balogh; David Victor; Emad H Asham; Sherilyn Gordon Burroughs; Maha Boktour; Ashish Saharia; Xian Li; R Mark Ghobrial; Howard P Monsour Journal: J Hepatocell Carcinoma Date: 2016-10-05
Authors: An Tang; Karma Abukasm; Guilherme Moura Cunha; Bin Song; Jin Wang; Mathilde Wagner; Christoph F Dietrich; Giuseppe Brancatelli; Kazuhiko Ueda; Jin-Young Choi; Diego Aguirre; Claude B Sirlin Journal: Abdom Radiol (NY) Date: 2021-01
Authors: Sang Min Lee; Jeong Min Lee; Su Joa Ahn; Hyo Jin Kang; Hyun Kyung Yang; Jeong Hee Yoon Journal: Korean J Radiol Date: 2021-03-09 Impact factor: 3.500